How short-term gain can lead to long-term pain

@inproceedings{James2017HowSG,
  title={How short-term gain can lead to long-term pain},
  author={David James},
  year={2017}
}
For the commercial success of advanced therapies including CAR-T, they must not only be safe and effective, but also consistently produced and delivered to patients at a cost substantially less than the reimbursable rate. Regardless of whether your therapy is allogeneic or autologous, initial protocols are usually developed using laboratory equipment and skilled research staff completing aseptic operations in biological safety cabinets. What many advanced therapy companies either fail to… Expand

Figures and Topics from this paper

Automation: what will the cell therapy laboratory of the future look like?
With the recent successes of CAR-T cell therapies there has been a renewed interest in bioprocessing and the manufacturing facilities required to meet the demands. Increasing the scale of any processExpand
Cell therapy products are revolutionizing multiple therapeutic areas; to maintain this pace of innovation, manufacturing solutions must adapt
TLDR
The migration to closed, automated, and scalable manufacturing platforms will provide an avenue to decrease therapeutic cost, while maintaining quality and increasing patient access, which is critical for the field’s continued evolution. Expand
When Origin Matters: Properties of Mesenchymal Stromal Cells From Different Sources for Clinical Translation in Kidney Disease
TLDR
This article provides a summary of important cell culture processing variables to consider in the scale-up of MSC manufacturing as well as giving a comprehensive review of tissue of origin-specific biological characteristics of M SCs and their use in current clinical trials in a range of renal pathologies. Expand
Acceleration of Translational Mesenchymal Stromal Cell Therapy Through Consistent Quality GMP Manufacturing
TLDR
This review highlights the bottlenecks associated with hMSC-based therapies and proposes solutions for consistent GMP manufacturing of hMSCs starting from raw materials selection, closed and modular systems of manufacturing, characterization, functional testing, quality control, and safety testing for release criteria. Expand
The Gibco™ CTS™ Rotea™ system story-a case study of industry-academia collaboration.
TLDR
The origin story of the Rotea system is described and how a chance meeting between a co-inventor and an academic cell biologist took the invention from a garage workshop to the world stage. Expand